Related references
Note: Only part of the references are listed.Clot lysis time and the risk of myocardial infarction and ischaemic stroke in young women; results from the RATIO case-control study
Bob Siegerink et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Impaired fibrinolytic capacity and increased fibrin formation associate with myocardial infarction
Karin Leander et al.
THROMBOSIS AND HAEMOSTASIS (2012)
Is HIV-1 infection associated with endothelial dysfunction in a population of African ancestry in South Africa?
C. Fourie et al.
Cardiovascular Journal of Africa (2011)
Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey
Salim Yusuf et al.
LANCET (2011)
Fibrinogen concentration and its role in CVD risk in black South Africans - effect of urbanisation
Marlien Pieters et al.
THROMBOSIS AND HAEMOSTASIS (2011)
Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1
Mirjam E. Meltzer et al.
BLOOD (2010)
Prognostic Value of Plasma Fibrinolysis Activation Markers in Cardiovascular Disease
Diana A. Gorog
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
The Prospective Urban Rural Epidemiology (PURE) study: Examining the impact of societal influences on chronic noncommunicable diseases in low-, middle-, and high-income countries
Koon Teo et al.
AMERICAN HEART JOURNAL (2009)
Reduced plasma fibrinolytic capacity as a potential risk factor for a first myocardial infarction in young men
Mirjam E. Meltzer et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Hypofibrinolysis is a risk factor for arterial thrombosis at young age
Ana H. C. Guimaraes et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity
K. G. M. M. Alberti et al.
CIRCULATION (2009)
Synergistic effects of hypofibrinolysis and genetic and acquired risk factors on the risk of a first venous thrombosis
Mirjam E. Meltzer et al.
PLOS MEDICINE (2008)
Heritability of clot formation, morphology, and lysis - The EuroCLOT study
Angela M. Carter et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
The relative kinetics of clotting and lysis provide a biochemical rationale for the correlation between elevated fibrinogen and cardiovascular disease
P. Y. Kim et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Risk factors associated with myocardial infarction in Africa - The INTERHEART Africa study
K Steyn et al.
CIRCULATION (2005)
Reduced plasma fibrinolytic potential is a risk factor for venous thrombosis
T Lisman et al.
BLOOD (2005)
The emergence of cardiovascular disease during urbanisation of Africans
HH Vorster
PUBLIC HEALTH NUTRITION (2002)
Stromal cells are the main plasminogen activator inhibitor-1-producing cells in human fat - Evidence of differences between visceral and subcutaneous deposits
D Bastelica et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Global burden of cardiovascular diseases - Part II: Variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies
S Yusuf et al.
CIRCULATION (2001)
Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis
T Lisman et al.
GASTROENTEROLOGY (2001)
Plasminogen activator inhibitor 1, transforming growth factor-β1, and BMI are closely associated in human adipose tissue during morbid obesity
MC Alessi et al.
DIABETES (2000)
Share Paper
